These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 12138664

  • 1. Nalidixic acid susceptibility test to screen ciprofloxacin resistance in Salmonella typhi.
    Kapil A, Renuka, Das B.
    Indian J Med Res; 2002 Feb; 115():49-54. PubMed ID: 12138664
    [Abstract] [Full Text] [Related]

  • 2. Predictive efficacy of nalidixic acid resistance as a marker of fluoroquinolone resistance in Salmonella enterica var Typhi.
    Ray P, Sharma J, Marak RS, Garg RK.
    Indian J Med Res; 2006 Jul; 124(1):105-8. PubMed ID: 16926465
    [Abstract] [Full Text] [Related]

  • 3. Nalidixic acid screening test in detection of decreased fluoroquinolone susceptibility in Salmonella typhi isolated from blood.
    Zafar A, Ibrahim NG, Ahsan T, Abbas Z, Zaidi A, Hasan R.
    J Coll Physicians Surg Pak; 2005 Jul; 15(7):413-7. PubMed ID: 16197870
    [Abstract] [Full Text] [Related]

  • 4. Low-level quinolone-resistance in multi-drug resistant typhoid.
    Mirza SH, Khan MA.
    J Coll Physicians Surg Pak; 2008 Jan; 18(1):13-6. PubMed ID: 18452661
    [Abstract] [Full Text] [Related]

  • 5. Novel restriction enzyme SSiI for the detection of mutation in GyrA gene of Salmonella enterica serovar Typhi.
    Agrawal P, Kapila K, Kumar S, Ghosh AN, Maurya AK.
    Indian J Pathol Microbiol; 2010 Jan; 53(3):509-12. PubMed ID: 20699513
    [Abstract] [Full Text] [Related]

  • 6. Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series.
    Slinger R, Desjardins M, McCarthy AE, Ramotar K, Jessamine P, Guibord C, Toye B.
    BMC Infect Dis; 2004 Sep 20; 4():36. PubMed ID: 15380025
    [Abstract] [Full Text] [Related]

  • 7. Validity of nalidixic acid screening in fluoroquinolone-resistant typhoid salmonellae.
    Butt T, Khan MY, Ahmad RN, Salman M, Afzal RK.
    J Coll Physicians Surg Pak; 2006 Jan 20; 16(1):31-4. PubMed ID: 16441985
    [Abstract] [Full Text] [Related]

  • 8. Current pattern in antimicrobial susceptibility of Salmonella Typhi isolates in Pondicherry.
    Madhulika U, Harish BN, Parija SC.
    Indian J Med Res; 2004 Aug 20; 120(2):111-4. PubMed ID: 15347861
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Is nalidixic acid screening still valid for the detection of reduced susceptibility of fluoroquinolone with Salmonella Typhi?
    Irfan S, Jabeen K, Jilani UA, Ahmed B, Mehraj J, Ahsan T, Zafar A.
    J Infect Dev Ctries; 2012 Oct 19; 6(10):700-3. PubMed ID: 23103891
    [Abstract] [Full Text] [Related]

  • 11. Reduced susceptibility to ciprofloxacin and gyra gene mutation in North Indian strains of Salmonella enterica serotype Typhi and serotype Paratyphi A.
    Renuka K, Kapil A, Kabra SK, Wig N, Das BK, Prasad VV, Chaudhry R, Seth P.
    Microb Drug Resist; 2004 Oct 19; 10(2):146-53. PubMed ID: 15256030
    [Abstract] [Full Text] [Related]

  • 12. Trends in antimicrobial susceptibility of Salmonella Typhi from North India (2001-2012).
    Singhal L, Gupta PK, Kale P, Gautam V, Ray P.
    Indian J Med Microbiol; 2014 Oct 19; 32(2):149-52. PubMed ID: 24713900
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Increase in minimum inhibitory concentration to quinolones and ceftriaxone in salmonellae causing enteric fever.
    Sekar U, Srikanth P, Kindo AJ, Babu VP, Ramasubramanian V.
    J Commun Dis; 2003 Sep 19; 35(3):162-9. PubMed ID: 15796408
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Salmonella enterica serovar Paratyphi A: an emerging cause of febrile illness in Nepal.
    Acharya D, Bhatta DR, Malla S, Dumre SP, Adhikari N, Kandel BP.
    Nepal Med Coll J; 2011 Jun 19; 13(2):69-73. PubMed ID: 22364084
    [Abstract] [Full Text] [Related]

  • 19. Reevaluating fluoroquinolone breakpoints for Salmonella enterica serotype Typhi and for non-Typhi salmonellae.
    Crump JA, Barrett TJ, Nelson JT, Angulo FJ.
    Clin Infect Dis; 2003 Jul 01; 37(1):75-81. PubMed ID: 12830411
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.